Back
Eagle Pharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
20
EGRX
Eagle Pharmaceuticals
Last Price:
0.80
Seasonality Move:
-1.64%
Sell
49
VRCA
Verrica Pharmaceuticals
Last Price:
0.80
Seasonality Move:
31.35%
Sell
20
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.50. The Score for EGRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.44. The Score for VRCA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 31.92 | Sell |
| Chaikin Money Flow: | -17488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.12 - 1.88) | Sell |
| Bollinger Bands (100): | (2 - 5.58) | Sell |
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 42.59 | Sell |
| Chaikin Money Flow: | -258225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.57) | Sell |
| Bollinger Bands (100): | (1.43 - 6.87) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Sell |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 2.66 | Sell |
| 200-day SMA: | 4.39 | Sell |
| 8-day EMA: | 0.56 | Sell |
| 20-day EMA: | 0.97 | Sell |
| 50-day EMA: | 2.16 | Sell |
| 200-day EMA: | 5.34 | Sell |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.53 | Sell |
| 20-day SMA: | 1.47 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 5.34 | Sell |
| 8-day EMA: | 1.51 | Sell |
| 20-day EMA: | 1.54 | Sell |
| 50-day EMA: | 2.18 | Sell |
| 200-day EMA: | 4.45 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.70 per share.
Eagle Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verrica Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||